E-LIB Suche - Ergebnisse für: Duyster, J

1

Pixantrone containing R‐CPOP as firstline treatment in elde..:

Marks, R. ; Lorenz, K. ; Trepel, M....
Hematological Oncology. 41 (2023) S2 - p. 425-426 , 2023

Link: https://doi.org/10.1002/..

2

Geriatric assessment scores: Predictors of prognosis and pr..:

Isbell, L. K. ; Vreden, A. ; Ihorst, G....
Hematological Oncology. 41 (2023) S2 - p. 407-408 , 2023

Link: https://doi.org/10.1002/..

3

S230: HUMAN ΒETA-DEFENSIN 2 TREATMENT MODULATES THE INTESTI..:

Rückert, T. ; Andrieux, G. ; Boerries, M....
HemaSphere. 6 (2022) - p. 131-132 , 2022

Link: https://doi.org/10.1097/..

4

PB2126: R-CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS W..:

Lorenz, K. ; Strüßmann, T. ; Trepel, M....
HemaSphere. 6 (2022) - p. 1997-1998 , 2022

Link: https://doi.org/10.1097/..

5

MATRIX INDUCTION FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLAN..:

Mutter, J. A. ; Alig, S. ; Lauer, E. M....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

6

NONINVASIVE DETECTION, CLASSIFICATION, AND RISK STRATIFICAT..:

Mutter, J. A. ; Alig, S. ; Lauer, E. M....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

Correction to: Prognostic factors for survival after alloge..:

Greil, C. ; Engelhardt, M. ; Ihorst, G....
Bone Marrow Transplantation. 56 (2021) 8 - p. 2042-2042 , 2021

Link: https://doi.org/10.1038/..

8

Prognostic factors for survival after allogeneic transplant..:

Greil, C. ; Engelhardt, M. ; Ihorst, G....
Bone Marrow Transplantation. 56 (2020) 4 - p. 841-852 , 2020

Link: https://doi.org/10.1038/..

9

Combined androgen deprivation therapy in recurrent androgen..:

Poxleitner, P. ; Shoumariyeh, K. ; Steybe, D....
Journal of Stomatology, Oral and Maxillofacial Surgery. 121 (2020) 5 - p. 599-603 , 2020

Link: https://doi.org/10.1016/..

10

MicroRNA-146a reduces MHC-II expression via targeting JAK/S..:

Stickel, N ; Hanke, K ; Marschner, D...
Leukemia. 31 (2017) 12 - p. 2732-2741 , 2017

Link: https://doi.org/10.1038/..

11

IDENTIFICATION AND CHARACTERISATION OF THE LYMPHOMA‐INITIAT..:

Illert, A.L. ; Kreutmair, S. ; Klingeberg, C....
Hematological Oncology. 35 (2017) S2 - p. 163-163 , 2017

Link: https://doi.org/10.1002/..

12

Lineage-specific STAT5 target gene activation in hematopoie..:

Müller, T A ; Grundler, R ; Istvanffy, R...
Leukemia. 30 (2016) 8 - p. 1725-1733 , 2016

Link: https://doi.org/10.1038/..

13

Prospective assessment of a comorbidity and functional geri..:

Zober, A. ; Möller, M. ; Pantic, M....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e121 , 2015

Link: https://doi.org/10.1016/..

14

Vorinostat (V), bortezomib (B), doxorubicin (Dox) and dexam..:

Keller, A. ; Waldschmidt, J.M. ; Wider, D....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e276-e277 , 2015

Link: https://doi.org/10.1016/..

15

Trained clinical nurse specialists proficiently obtain bone..:

Naegele, M. ; Leppla, L. ; Kiote-Schmidt, C....
Annals of Hematology. 94 (2015) 9 - p. 1577-1584 , 2015

Link: https://doi.org/10.1007/..